Comments
Loading...

Galectin Therapeutics

GALTNASDAQ
Logo brought to you by Benzinga Data
$2.71
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed

Galectin Therapeutics (NASDAQ:GALT) Stock, Earnings Estimates, EPS, And Revenue

Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 11
EPS Estimate
$-0.200
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)

Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Galectin Therapeutics (GALT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-13$-0.20$-0.16-25.0 %
Mar 20242024-05-15$-0.19$-0.16-18.8 %
Dec 20232024-03-29$-0.16$-0.160.00 %
Sep 20232023-11-13$-0.24$-0.16-50.0 %

Galectin Therapeutics (GALT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

A

Galectin Therapeutics (GALT) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?

A

The Actual EPS was $-0.20, which missed the estimate of $-0.16.

Q

What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch